Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of the Trump administration’s policies on pricing and tariffs.
Pfizer study finds patients lose up to 12% of their weight after taking once-a-month drug
Related Posts
Popular News
Latest News
How World Liberty’s $3.4B USD1 Stablecoin Powers Onchain Lending Markets
Key takeawaysWorld Liberty Financial has entered DeFi lending with the launch of World Liberty Markets, an onchain borrowing and lending...
Now that SpaceX and xAI have merged, is Tesla next?
Experts are split on the merits of a possible Tesla-SpaceX combination, which could further Elon Musk’s dream of corporate “convergence,”...
3 Tips On How To Manage Your CSU Diagnosis
When Emmeka, an Iowa-based social media manager and beauty content creator, first noticed itchy, red, welt-like bumps across her back,...
This QLED TV Packs Serious Brightness and Gaming Specs for Under $800
We may earn a commission from links on this page. Deal pricing and availability subject to change after time of...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.